Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Feb;135(2):411-417.
doi: 10.1038/jid.2014.402. Epub 2014 Sep 17.

Toll-like receptor 3 increases allergic and irritant contact dermatitis

Affiliations
Free article

Toll-like receptor 3 increases allergic and irritant contact dermatitis

Naomi Nakamura et al. J Invest Dermatol. 2015 Feb.
Free article

Abstract

There is increasing recognition of the role of Toll-like receptor 3 (TLR3) in noninfectious inflammatory diseases, but the function of TLR3 in inflammatory skin diseases is unclear. We investigated the functions of TLR3 in allergic and irritant contact dermatitis (ICD). The contact hypersensitivity (CHS) response was lower in Toll-like receptor 3 knockout (Tlr3 KO) mice, and was greater in TLR3 transgenic (Tg) mice than in wild-type (WT) mice after challenge with 2,4,6-trinitro-1-chlorobenzene. Adoptive transfer of immunized lymph node cells from Tlr3 KO mice induced CHS in WT recipients. In contrast, adoptive transfer of those from WT mice did not fully induce CHS in Tlr3 KO recipients. The ICD reaction following croton oil application was lower in Tlr3 KO mice, and was greater in TLR3 Tg mice than in WT mice. Maturation, migration, and antigen presentation of dendritic cells and proliferation of lymphocytes between WT mice and Tlr3 KO mice were comparable. These results show that TLR3 enhances antigen-independent skin inflammation in the elicitation phase of allergic contact dermatitis and in ICD.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Invest Dermatol. 2013 Feb;133(2):303-15 - PubMed
    1. Arch Dermatol Res. 2002 Jan;293(11):552-9 - PubMed
    1. J Allergy Clin Immunol. 2008 Aug;122(2):391-9, 399.e1-5 - PubMed
    1. Nat Immunol. 2001 Aug;2(8):675-80 - PubMed
    1. Int Immunol. 2002 Sep;14(9):1065-74 - PubMed

Publication types